Description

Alaktin (Cabergoline) tablets 0.5 mg. №2 vial

Ingredients

Active ingredient: Cabergoline 0.5 mg per tablet.

Dosage

Dosage: The usual recommended dose is 0.25 mg twice a week. Dosage may vary based on individual response and medical condition.

Indications

Indications: Alaktin tablets are indicated for the treatment of hyperprolactinemia, disorders associated with high levels of prolactin hormone.

Contraindications

Contraindications: Do not use Alaktin tablets if you are allergic to cabergoline or any other ingredients in the product. Consult a healthcare provider before use.

Directions

Directions: Take Alaktin tablets orally with or without food as directed by your healthcare provider. Do not exceed the recommended dose.

Scientific Evidence

Cabergoline, the active ingredient in Alaktin tablets, is a dopamine receptor agonist that works by reducing the secretion of prolactin from the pituitary gland. Studies have shown that cabergoline is effective in normalizing prolactin levels and improving symptoms associated with hyperprolactinemia.

Research published in the Journal of Clinical Endocrinology & Metabolism demonstrated the efficacy of cabergoline in treating hyperprolactinemia and its safety profile in long-term use. The study concluded that cabergoline is a well-tolerated and effective treatment option for patients with hyperprolactinemia.

Additional Information

It is important to follow the dosage instructions provided by your healthcare provider to achieve the best results with Alaktin tablets. Regular monitoring of prolactin levels may be necessary during treatment to assess the response to therapy.

Discuss with your healthcare provider about any other medications or medical conditions you have before starting Alaktin tablets to avoid potential drug interactions or complications.